Sprint Bioscience Future Growth
Future criteria checks 3/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Sprint Bioscience.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Biotechs earnings growth | 36.6% |
Revenue growth rate | 49.5% |
Future return on equity | 34.1% |
Analyst coverage | Low |
Last updated | 11 May 2023 |
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 85 | N/A | 10 | 10 | 1 |
12/31/2024 | 98 | N/A | 32 | 32 | 1 |
12/31/2023 | 60 | N/A | 2 | 2 | 1 |
3/31/2020 | 35 | -23 | -12 | -12 | N/A |
12/31/2019 | 34 | -22 | -28 | -28 | N/A |
9/30/2019 | 21 | -31 | -27 | -35 | N/A |
6/30/2019 | 19 | -33 | -48 | -52 | N/A |
3/31/2019 | 3 | -47 | -52 | -53 | N/A |
12/31/2018 | 18 | -32 | -30 | -29 | N/A |
9/30/2018 | 31 | -19 | -30 | -20 | N/A |
6/30/2018 | 32 | -15 | -21 | -12 | N/A |
3/31/2018 | 41 | -5 | -14 | -7 | N/A |
12/31/2017 | 33 | -11 | -32 | -23 | N/A |
9/30/2017 | 41 | -1 | -29 | -19 | N/A |
6/30/2017 | 47 | 5 | -5 | 6 | N/A |
3/31/2017 | 53 | 8 | -4 | 7 | N/A |
12/31/2016 | 47 | 5 | N/A | 8 | N/A |
9/30/2016 | 40 | -2 | N/A | 8 | N/A |
6/30/2016 | 34 | -5 | N/A | 0 | N/A |
3/31/2016 | 17 | -14 | N/A | -1 | N/A |
12/31/2015 | 13 | -15 | N/A | 1 | N/A |
9/30/2015 | 10 | -15 | N/A | 2 | N/A |
6/30/2015 | 6 | -15 | N/A | -14 | N/A |
3/31/2015 | 6 | -13 | N/A | -11 | N/A |
12/31/2014 | 5 | -11 | N/A | -11 | N/A |
9/30/2014 | 5 | -9 | N/A | -8 | N/A |
6/30/2014 | 5 | -7 | N/A | -6 | N/A |
3/31/2014 | 6 | -6 | N/A | -5 | N/A |
12/31/2013 | 8 | -4 | N/A | -4 | N/A |
12/31/2012 | 4 | -4 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if SPRINT's forecast earnings growth is above the savings rate (0.6%).
Earnings vs Market: Insufficient data to determine if SPRINT's earnings are forecast to grow faster than the Swedish market
High Growth Earnings: Insufficient data to determine if SPRINT's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: SPRINT's revenue (49.5% per year) is forecast to grow faster than the Swedish market (5.4% per year).
High Growth Revenue: SPRINT's revenue (49.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SPRINT's Return on Equity is forecast to be high in 3 years time (34.1%)